Emma Aarnio

Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Petrova, Miriam; Paduchova, Martina; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Masarykova, Lucia; Alfian, Sofa D.; Aarnio, Emma. 2023. Biomedicines. 11: A1 Journal article (refereed), original research

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes

Lavikainen, Piia; Aarnio, Emma; Linna, Miika; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne. 2022. PLoS ONE. 17: A1 Journal article (refereed), original research

Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Masarykova, Lucia; Alfian, Sofa D.; Aarnio, Emma. 2022. Biomedicines. 10: A1 Journal article (refereed), original research

Muutokset tyypin 2 diabetespotilaiden maksamissa lääkkeiden omavastuissa vuoden 2017 lääkekorvausmuutoksen jälkee

Parkkila, Ville; Lavikainen, Piia; Martikainen, Janne; Aarnio, Emma . 2022. Dosis. 38: 214–234 A1 Journal article (refereed), original research

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study

Ágh, Tamás; Hadžiabdić, Maja Ortner; Garuoliene, Kristina; Granas, Anne Gerd; Aarnio, Emma; Menditto, Enrica; Gregório, João; Barnestein-Fonseca, Pilar; Mevsim, Vildan; Kardas, Przemysław. 2022. Frontiers in pharmacology. 13: A1 Journal article (refereed), original research

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Biomedicines. 9: 1800 A1 Journal article (refereed), original research

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Jalkanen, Kari; Järvenpää, Riia; Tilles-Tirkkonen, Tanja; Martikainen, Janne; Aarnio, Emma; Männikkö, Reija; Rantala, Eeva; Karhunen, Leila; Kolehmainen, Marjukka; Harjumaa, Marja; Poutanen, Kaisa; Ermes, Miikka; Absetz, Pilvikki; Schwab, Ursula; Lakka, Timo; Pihlajamäki, Jussi; Lindström, Jaana; The StopDia Study Group. 2021. JMIR diabetes. 6: e21356 A1 Journal article (refereed), original research

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla

Ojala, Oona; Aarnio, Emma; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne; Lavikainen, Piia. 2021. Lääkärilehti. 76: 48-52 A1 Journal article (refereed), original research

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Frontiers in pharmacology. 12: 687549 A1 Journal article (refereed), original research

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Jalkanen, Kari; Aarnio, Emma; Lavikainen, Piia; Lindström, Jaana; Peltonen, Markku; Laatikainen, Tiina; Martikainen, Janne. 2021. Bmc health services research. 21: 916 A1 Journal article (refereed), original research

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Biomedicines. 9: 1280 A1 Journal article (refereed), original research

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Härkönen, Ulla; Rannanheimo, Piia; Leppänen, Laura; Aarnio, Emma. 2021. Sic!. : 5 s, D1 Article in a trade journal

Vaikuttavuuden vuosikymmentä rakentamassa : Kansallinen sosiaali- ja terveydenhuollon vaikuttavuuskeskus -selvitys

Torkki, Paulus; Mäki-Opas, Tomi; Vanhala, Antero; Auvinen, Terhi; Aarnio, Emma; Pitkänen, Laura; Linnosmaa, Ismo; Leskelä, Riikka-Leena; Paronen, Elsa; Malmivaara, Antti; Lammintakanen, Johanna; Martikainen, Janne; Heiskanen, Jari. 2021. . . Helsingin yliopisto; Itä-Suomen yliopisto D4 Published development or research report or study

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

Wawruch, Martin; Wimmer Jr, Gejza; Murin, Jan; Paduchova, Martina; Tesar, Tomas; Hlinkova, Lubica; Slavkovsky, Peter; Aarnio, Emma. 2020. Drugs and aging. 37: 595-604 A1 Journal article (refereed), original research

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Aarnio, Emma; Huupponen, Risto; Martikainen, Jaana E; Korhonen, Maarit J. 2020. Research in social and administrative pharmacy. 16: 553-559 A1 Journal article (refereed), original research

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Lavikainen, Piia; Aarnio, Emma; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne. 2020. Bmc health services research. 20: 1095 A1 Journal article (refereed), original research

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Wawruch, Martin; Wimmer, Gejza Jr; Murin, Jan; Paduchova, Martina; Petrova, Miriam; Tesar, Tomas; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2020. Biomedicines. 8: 378 A1 Journal article (refereed), original research

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Lavikainen, Piia; Aarnio, Emma; Niskanen, Leo; Mäntyselkä, Pekka; Martikainen, Janne. 2020. Health policy. 124: 1310-1316 A1 Journal article (refereed), original research

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Sääskilahti, Maria; Aarnio, Emma; Lämsä, Elina; Ahonen, Riitta; Timonen, Johanna. 2020. Journal of pharmaceutical health services research. 11: 335-342 A1 Journal article (refereed), original research

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Törmälehto, S; Aarnio, E; Mononen, ME; Arokoski, JPA; Korhonen, RK; Martikainen, JA. 2019. PLoS ONE. 14: e0219902 A1 Journal article (refereed), original research

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

Jalkanen, K; Aarnio, E; Lavikainen, P; Jauhonen, HM; Enlund, H; Martikainen, J. 2019. Health and quality of life outcomes. 17: 117 A1 Journal article (refereed), original research

Methodological Considerations in Pharmacoepidemiology and Pharmacovigilance Studies

Koponen, Marjaana; Ilomäki, Jenni; Aarnio, Emma; Taipale, Heidi. Teoksessa: Babar, Zaheer-Ud-Din, 2019. Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Volume 2. s. 435-444. Academic press D2 Article in a professional book (incl. an introduction by the editor)

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

Wawruch M; Wimmer G Jr; Murin J; Paduchova M; Tesar T; Hlinkova L; Slavkovsky P; Fabryova L; Aarnio E. 2019. Drugs and aging. 36: 863-873 A1 Journal article (refereed), original research

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Suviranta, T; Timonen, J; Martikainen, J; Aarnio, E. 2019. Bmc health services research. 19: 769 A1 Journal article (refereed), original research

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Törmälehto, Soili; Mononen, Mika E; Aarnio, Emma; Arokoski, Jari P A; Korhonen, Rami K; Martikainen, Janne. 2018. Health and quality of life outcomes. 16: 154 A1 Journal article (refereed), original research

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Aarnio, Emma; Huupponen, Risto; Hämeen-Anttila, Katri; Merikoski, Merja; Puhakka, Jaana; Korhonen, Maarit J. 2018. Basic and clinical pharmacology and toxicology. 2019; 124: 416-422 A1 Journal article (refereed), original research

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Aarnio Emma. 2017. Publications of the University of Eastern Finland. Dissertations in Health Sciences G5 Doctoral dissertation (article)

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Aarnio Emma, Martikainen Janne. 2016. Sic!. 6: 48-49 D1 Article in a trade journal

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Aarnio Emma, Martikainen Janne, Winn Aaron N, Huupponen Risto, Vahtera Jussi, Korhonen Maarit J. 2016. Circulation: cardiovascular quality and outcomes. 9: 704-713 A1 Journal article (refereed), original research

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Aarnio Emma, Korhonen Maarit J, Huupponen Risto, Martikainen Janne. 2015. Atherosclerosis. 239: 240-247 A1 Journal article (refereed), original research

Measurement of statin exposure in the absence of information on prescribed doses

Romppainen Tomi, Rikala Maria, Aarnio Emma, Korhonen Maarit J, Saastamoinen Leena K, Huupponen Risto. 2014. European journal of clinical pharmacology. 70: 1275-1276 A1 Journal article (refereed), original research

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events

Helin-Salmivaara Arja, Lavikainen Piia, Aarnio Emma, Huupponen Risto, Korhonen Maarit J. 2014. PLoS ONE. 9: e90325 A1 Journal article (refereed), original research

Register-based predictors of adherence among new statin users in Finland

Aarnio Emma J, Martikainen Janne A, Helin-Salmivaara Arja, Huupponen Risto K, Hartikainen Juha E.K, Peura Piia K, Korhonen Maarit J. 2013. Journal of clinical lipidology. 2014:8: 117-125 A1 Journal article (refereed), original research

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Purmonen Timo, Pänkäläinen Emma, Turunen Juha, Asseburg Christian, Martikainen Janne. 2011. Acta oncologica. 50: 344 - 352 A1 Journal article (refereed), original research

Research groups

Projects

Keywords

Publications

Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes

Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease

Muutokset tyypin 2 diabetespotilaiden maksamissa lääkkeiden omavastuissa vuoden 2017 lääkekorvausmuutoksen jälkee

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Vaikuttavuuden vuosikymmentä rakentamassa : Kansallinen sosiaali- ja terveydenhuollon vaikuttavuuskeskus -selvitys

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

Methodological Considerations in Pharmacoepidemiology and Pharmacovigilance Studies

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Measurement of statin exposure in the absence of information on prescribed doses

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events

Register-based predictors of adherence among new statin users in Finland

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Emma Aarnio

Research groups

Projects

Keywords

Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes

Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease

Muutokset tyypin 2 diabetespotilaiden maksamissa lääkkeiden omavastuissa vuoden 2017 lääkekorvausmuutoksen jälkee

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Insuliinihoidon aloittamisen ajankohta ja perusteet ­ tyypin 2 diabetekseen sairastuneilla

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Vaikuttavuuden vuosikymmentä rakentamassa : Kansallinen sosiaali- ja terveydenhuollon vaikuttavuuskeskus -selvitys

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

Methodological Considerations in Pharmacoepidemiology and Pharmacovigilance Studies

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Measurement of statin exposure in the absence of information on prescribed doses

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events

Register-based predictors of adherence among new statin users in Finland

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla